PATENT CLAIM ANALYSIS

Application Number: 16104561
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "234500"]

Abstract:
The present invention relates to heterocyclic compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.

Claim (Index 43):
The method as recited in  claim 36 , wherein the cancer is selected from non-small cell lung cancer, small cell lung cancer, pancreatic cancer, biliary tract cancer, head and neck cancer, bladder cancer, colorectal cancer, glioblastoma, esophageal cancer, breast cancer, hepatocellular carcinoma, and ovarian cancer.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 96.0
- Lexical Diversity: 1.04
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16035310', '15990283', '13655164', '15486017', '13547314']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7636423449549984
- 35 USC 102 Novelty (BERT): 0.5724429182497668
- Combined Prediction Score: 0.7445224022844753
- Mean Citation Score: 330.5083120000001
- Max Citation Score: 447.91846
- Similarity Product: 380.860534153856

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test